Inventor · disambiguated record
Jing Xie
Also filed as: XIE JING · XIE JING-XI
10 granted patents·8 pending applications·22 citations·filing 1995–2023
84Inventor score
Files withSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD6BEIJING JIYUAN BIOLOGICAL TECH CO LTD2CN SHENHUA COAL LIQUID & CHEM2DUAN HAIFENG2BIOTECH RESEARCH LAB INC1
Top patents by PatentIndex Score
18 records- 0179US10815197B2N-sulfonyl benzamides as voltage-gated sodium channel inhibitorsSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Oct 27, 2020·2 cites·2 claims
- 0278US11155546B24,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Oct 26, 2021·1 cites·19 claims
- 0377US10435400B22,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefromSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 8, 2019·3 cites·9 claims
- 0475US11771780B2Method for preparing an Fe-tCDTA contrast agent and product obtainable by the methodUNIV BERLIN CHARITE·Filed 2019·Granted Oct 3, 2023·2 cites·6 claims
- 0573US12414966B2Method of treating diabetes with FGF21 and GLP1 double gene-modified cellBEIJING JIYUAN BIOLOGICAL TECH CO LTD·Filed 2023·Granted Sep 16, 2025·0 cites·19 claims
- 0673US11752173B2FGF21 and GLP1 double gene-modified mesenchymal stem cell and use in treating a metabolic diseaseBEIJING JIYUAN BIOLOGICAL TECH CO LTD·Filed 2018·Granted Sep 12, 2023·1 cites·20 claims
- 0767US6858648B2Laetispicine and laetispicine analogues, methods of use and preparationUNIV FUDAN·Filed 2003·Granted Feb 22, 2005·8 cites·14 claims
- 0856US11174254B2Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2018·Granted Nov 16, 2021·0 cites·12 claims
- 0955US2024287026A1Triazinylmethylcycloalkylcarboxylic acid derivative, and pharmaceutical composition and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 1055US2025235856A1Molybdenum amine complex catalyst and preparation method therefor and use thereofCN SHENHUA COAL LIQUID & CHEM·Filed 2023·Application pending·0 cites
- 1150US5612341ABrominated hexahydroxybiphenyl derivativesBIOTECH RESEARCH LAB INC·Filed 1995·Granted Mar 18, 1997·5 cites·20 claims
- 1250US2022096598A1Fibroblast growth factor 21 variant, and fusion protein and use thereofDUAN HAIFENG·Filed 2019·Application pending·0 cites
- 1347US2021388326A1Sphingosine kinase 1 and fusion protein comprising the same and use thereofDUAN HAIFENG·Filed 2019·Application pending·0 cites
- 1447US2023174710A1Hydroxyl-terminated polyester resin, preparation method therefor and use thereofKINTE MATERIALS SCIENCE AND TECH CO LTD·Filed 2020·Application pending·0 cites
- 1546US12465659B2Iron(III) complexes having new contrast agent properties, for magnetic resonance imagingCHARITE—UNIVERSITAETSMEDIZIN BERLIN·Filed 2020·Granted Nov 11, 2025·0 cites·15 claims
- 1646US2025197729A1A recycling hydrogen-donating solvent for direct coal liquefaction and preparation method therefor and use thereofCN SHENHUA COAL LIQUID & CHEM·Filed 2023·Application pending·0 cites
- 1743US2014248254A1The use of ache as nucleaseZHANG XUEJUN·Filed 2012·Application pending·0 cites
- 1843US2020262813A11,5,7-trisubstituted isoquinoline derivatives, preparation thereof, and use thereof in medicinesSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jing Xie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →